Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGeiger Counter Regulatory News (GCL)

Share Price Information for Geiger Counter (GCL)

Share Price is delayed by 15 minutes
Get Live Data
72.80    2.20 (3.13%)
Bid:
71.00
Ask:
74.60
Spread: 3.60 (5.07%)
Market Cap: £91.33m
GCL Live PriceLast checked at - London Stock Exchange

Intraday Geiger Counter Share Chart

Subscription Rights Rump Placing

7 May 2026 08:55

RNS Number : 4097D
Geiger Counter Ltd
07 May 2026
 

Geiger Counter Limited (or the "Company")

7 May 2026

Exercise of outstanding Subscription Share Rights

 

The Company announces that further to the announcement on 6 May 2024, the Subscription Trustee has exercised all of the 6,815,308 outstanding Subscription Rights (the "Rump"). The ordinary shares of no par value in the capital of the Company ("Ordinary Shares") that arose from the exercise of the Rump have been sold by Cavendish Capital Markets Limited by way of a secondary market placing at a price of 70 pence per Ordinary Share, raising total gross proceeds for the Company of £2.5 million (based on the exercise price of 37.20 pence). The difference between the placing price and exercise price, after deduction of the costs (of exercising the Subscription Rights of the Rump and all the costs and expenses of the Subscription Trustee, the Registrar and the secondary market placing), being the resultant net proceeds, will be distributed by the Registrar to those shareholders who did not exercise their subscription rights, in proportion to their Shareholding on the Record Date, by 31 May 2026.

Accordingly, the Company announces that it will be issuing and allotting a further 6,815,308 Ordinary Shares, pertaining to the outstanding Subscription Rights exercised by the Subscription Trustee, subject to admission to trading. Application will be made for the new Ordinary Shares to be admitted to trading on the LSE. It is expected that dealings in the new Ordinary Shares will commence at 8.00 a.m. on 11 May 2026.

Following the exercise of all Subscription Rights, the Company has raised a total of £7.8 million (on the exercise price of 37.20 pence). The funds raised will be invested in a manner consistent with the stated investment objectives of the Company.

 

Total Voting Rights

For the purposes of the Financial Conduct Authority's Disclosure Guidance and Transparency Rules ("DTRs"), following Admission the issued ordinary share capital of the Company will consist of 173,641,396 Ordinary Shares, of which 47,838,208 shares are held in treasury by the Company, resulting in 125,803,188 Ordinary Shares with voting rights attached. This figure of 125,803,188 Ordinary Shares may be used by the Company's shareholders as the denominator for the calculation by which they will determine whether they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the DTRs.

 

The information contained within this RNS is considered to be inside information prior to its release.

 

Enquiries

 

Manulife | CQS Investment Management 

Craig Cleland

T: +44 (0) 20 7201 5368

Cavendish Capital Markets Limited

Tunga Chigovanyika

 (Corporate Finance)

T: +44 (0) 20 7397 1915

Daniel Balabanoff / Pauline Tribe (Sales)

T: +44 (0) 20 7220 0500

Summit Fund Services Jersey Limited

Christopher Foulds

T:+44 (0) 1534 825 259

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ARIUBVBRNUUVRRR
Date   Source Headline
19th May 202510:34 amRNSShare Buyback
16th May 20254:50 pmRNSNet Asset Value(s)
16th May 20258:45 amRNSShare Buyback
15th May 20251:12 pmRNSNet Asset Value(s)
15th May 20259:43 amRNSShare Buyback
14th May 20251:10 pmRNSNet Asset Value(s)
14th May 202510:02 amRNSShare Buyback
13th May 20253:14 pmRNSNet Asset Value(s)
13th May 202510:24 amRNSHolding(s) in Company
13th May 202510:04 amRNSShare Buyback
12th May 202512:28 pmRNSNet Asset Value(s)
9th May 202511:59 amRNSNet Asset Value(s)
8th May 20251:09 pmRNSNet Asset Value(s)
8th May 20259:22 amRNSShare Buyback
7th May 202512:25 pmRNSNet Asset Value(s)
7th May 20259:32 amRNSShare Buyback
7th May 20258:54 amRNSHolding(s) in Company
7th May 20257:00 amRNSNet Asset Value(s)
7th May 20257:00 amRNSNotification Shareholders - Subscription Rights
2nd May 20254:54 pmRNSNet Asset Value(s)
2nd May 20257:05 amRNSResult of subscription rights exercise
1st May 20252:58 pmRNSNet Asset Value(s)
30th Apr 20255:01 pmRNSNet Asset Value(s)
29th Apr 20252:00 pmRNSNet Asset Value(s)
28th Apr 20254:27 pmRNSNet Asset Value(s)
25th Apr 20253:00 pmRNSNet Asset Value(s)
25th Apr 202510:14 amRNSShare Buyback
24th Apr 20255:10 pmRNSNet Asset Value(s)
23rd Apr 20252:45 pmRNSNet Asset Value(s)
22nd Apr 20255:21 pmRNSNet Asset Value(s)
17th Apr 20253:16 pmRNSNet Asset Value(s)
17th Apr 202510:04 amRNSMonthly Factsheet- March 2025
16th Apr 20253:22 pmRNSNet Asset Value(s)
16th Apr 20258:17 amRNSHolding(s) in Company
15th Apr 20254:50 pmRNSNet Asset Value(s)
15th Apr 20258:49 amRNSHolding(s) in Company
11th Apr 20253:03 pmRNSNet Asset Value(s)
11th Apr 20258:44 amRNSHolding(s) in Company
10th Apr 20254:55 pmRNSNet Asset Value(s)
9th Apr 20252:58 pmRNSNet Asset Value(s)
8th Apr 20252:32 pmRNSNet Asset Value(s)
7th Apr 20252:53 pmRNSNet Asset Value(s)
7th Apr 20258:13 amRNSShare Buyback
4th Apr 20255:01 pmRNSNotification in regard to Subscription Rights
4th Apr 20252:43 pmRNSNet Asset Value(s)
4th Apr 20251:02 pmRNSNotification in regard to Subscription Rights
3rd Apr 20253:26 pmRNSNet Asset Value(s)
2nd Apr 20252:50 pmRNSNet Asset Value(s)
2nd Apr 202510:18 amRNSTotal Voting Rights- March 2025
1st Apr 20256:17 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.